Insulet Corporation Stock News

Insulet Corporation (NASDAQ:PODD ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 3:00 PM EDT Company Participants Ashley McEvoy - CEO, President & Director Ana Chadwick - Executive VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Welc...

Omnipod insulin pump maker recently reported triple-digit profit growth. Shares are in a buy zone.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Eric Benjamin to Chief Operating Officer effective immediately. The Company also announced the appointment of Manoj Raghunandanan as Chief Growth Officer. In this expanded role, M...

The Omnipod maker reported 113% earnings growth, sending shares higher.

Insulet is Tuesday's IBD Stock Of The Day after shares broke out following a "broad-based beat" for the June quarter.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the upcoming investor conferences (all Eastern Time): Wells Fargo 2025 Healthcare Conference in Boston on September 4 at 3:00 p.m. Baird 2025 Global Healthcare Conference in New York City on ...

These companies have shown the largest increases in sales per share while also improving profit margins

PODD delivered strong Q2 results, exceeding revenue guidance, improving gross margin, and launching the Omnipod 5 iPhone app, strengthening its ecosystem position. Omnipod 5's pharmacy channel penetration and positive clinical data support sustained >20% annual revenue growth and margin expansion over the next 3-5 years. The market underestimates the long-term impact of pharmacy distribution, w...